Abstract
The isoelectric point (pI) of the major form of Bence-Jones protein excreted by 62 patients with myeloma and six with macroglobulinaemia was measured by combining isoelectric focusing with immunoblotting techniques. The distribution of the pI values for both kappa and lambda type proteins was bimodal, most falling in the ranges 5.0-6.0 and 7.0-7.5. Plasma creatinine and creatinine clearance and the urine excretion of alpha-1-microglobulin and beta-2-microglobulin were measured in 24 of the patients. These patients, who were free of additional factors known to have an association with the development of renal impairment, were followed up for a mean period of 16 months (range three to 28 months). It was found that renal impairment was not related to the pI of the Bence-Jones protein excreted.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clyne D. H., Pesce A. J., Thompson R. E. Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point. Kidney Int. 1979 Sep;16(3):345–352. doi: 10.1038/ki.1979.137. [DOI] [PubMed] [Google Scholar]
- Cooper E. H., Forbes M. A., Crockson R. A., MacLennan I. C. Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial. J Clin Pathol. 1984 Aug;37(8):852–858. doi: 10.1136/jcp.37.8.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coward R. A., Delamore I. W., Mallick N. P., Robinson E. L. The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma. Clin Sci (Lond) 1984 Feb;66(2):229–232. doi: 10.1042/cs0660229. [DOI] [PubMed] [Google Scholar]
- Hill G. S., Morel-Maroger L., Méry J. P., Brouet J. C., Mignon F. Renal lesions in multiple myeloma: their relationship to associated protein abnormalities. Am J Kidney Dis. 1983 Jan;2(4):423–438. doi: 10.1016/s0272-6386(83)80075-4. [DOI] [PubMed] [Google Scholar]
- Johns E. A., Turner R., Cooper E. H., Maclennan I. C. Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity. J Clin Pathol. 1986 Aug;39(8):833–837. doi: 10.1136/jcp.39.8.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kyle R. A., Greipp P. R. "Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients. N Engl J Med. 1982 Mar 11;306(10):564–567. doi: 10.1056/NEJM198203113061002. [DOI] [PubMed] [Google Scholar]
- Norden A. G., Fulcher L. M., Flynn F. V. Detection of Bence-Jones protein by isoelectric focussing of unconcentrated urine followed by nitrocellulose blotting and immunoperoxidase staining. Clin Chim Acta. 1985 Dec 31;153(3):149–156. doi: 10.1016/0009-8981(85)90346-8. [DOI] [PubMed] [Google Scholar]
- Norden A. G., Fulcher L. M., Flynn F. V. Immunoglobulin light-chain immunoblots of urine proteins from patients with tubular and Bence-Jones proteinuria. Clin Chim Acta. 1987 Jul 15;166(2-3):307–315. doi: 10.1016/0009-8981(87)90434-7. [DOI] [PubMed] [Google Scholar]
- Rosanky S. J., Sartiano G. P., Lynch B., Gonzales F., Valdivieso J. Bence Jones proteinuria. N Engl J Med. 1982 Oct 14;307(16):1026–1027. doi: 10.1056/NEJM198210143071620. [DOI] [PubMed] [Google Scholar]
- Smolens P., Venkatachalam M., Stein J. H. Myeloma kidney cast nephropathy in a rat model of multiple myeloma. Kidney Int. 1983 Aug;24(2):192–204. doi: 10.1038/ki.1983.144. [DOI] [PubMed] [Google Scholar]
- Sølling K., Sølling J., Lanng Nielsen J. Polymeric Bence Jones proteins in serum in myeloma patients with renal insufficiency. Acta Med Scand. 1984;216(5):495–502. doi: 10.1111/j.0954-6820.1984.tb05037.x. [DOI] [PubMed] [Google Scholar]
- Weiss J. H., Williams R. H., Galla J. H., Gottschall J. L., Rees E. D., Bhathena D., Luke R. G. Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat. Kidney Int. 1981 Aug;20(2):198–210. doi: 10.1038/ki.1981.122. [DOI] [PubMed] [Google Scholar]